Latest Diabetes mellitus type 1 Stories

Study suggests a new approach could give patients the ability to make their own insulin-producing cells without a stem cell transplant A study by Columbia researchers suggests that cells in the patient's intestine could be coaxed into making insulin, circumventing the need for a stem cell transplant. Until now, stem cell transplants have been seen by many researchers as the ideal way to replace cells lost in type I diabetes and to free patients from insulin injections. The...

LONG ISLAND, N.Y., March 8, 2012 /PRNewswire-USNewswire/ -- The atmosphere will be "magical" and the fun-o-meter will be cranked up high as "Wizards of Waverly Place" star Jake T. Austin joins in the revelry at the 9th annual Kids Party for a Cure benefiting the cure-focused work of the Diabetes Research Institute (DRI). The family-oriented event will be held at Dave & Buster's at the Mall at The Source, 1504 Old Country Road in Westbury, on Sunday, March 25. The Party will...

XOMA Corporation (Nasdaq: XOMA) announced that its study of XMetA, the company's fully-human allosteric monoclonal antibody to the insulin receptor, is available online and will be published in the May issue of the American Diabetes Association's journal Diabetes. XMetA is the first antibody specific for the insulin receptor shown to correct hyperglycemia in a mouse model of diabetes. Results of a study conducted by XOMA and confirmed by investigators at the University of California, San...

NEW YORK, March 6, 2012 /PRNewswire/ -- Islet Sciences, Inc., a wholly-owned subsidiary of One E-Commerce Corporation (OTC.BB: ONCED), a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that the company has named George J. Todaro, M.D. and Jerry L. Nadler, M.D. to its Board of Directors. Dr. Todaro and Dr. Nadler join Joel D. Perlin, Dr. Jonathan...

Scientists at the Diabetes Research Institute have developed a revolutionary technique to provide critical oxygen for maintaining the survival of insulin-producing cells. This is the first time that scientists have been able to successfully deliver oxygen locally to beta cells using a biomaterial. The results of the study, which represents a major step toward the goal of developing an alternative site to house insulin-producing cells, were just published in the prestigious journal Proceedings...

MIAMI, March 1, 2012 /PRNewswire-USNewswire/ -- Scientists at the Diabetes Research Institute have developed a revolutionary technique to provide critical oxygen for maintaining the survival of insulin-producing cells. This is the first time that scientists have been able to successfully deliver oxygen locally to beta cells using a biomaterial. The results of the study, which represents a major step toward the goal of developing an alternative site to house insulin-producing cells,...

NEW YORK, Feb. 29, 2012 /PRNewswire/ -- Islet Sciences, Inc. (OTC.BB: ONCED), a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today announced that the company entered into a Share Exchange Agreement to acquire DiaKine Therapeutics, Inc. ("DTI"), a biopharmaceutical company developing new, proprietary drugs for unmet medical needs in diabetes and...

(Ivanhoe Newswire) – New research has found that insulin production may persist for decades after the onset of type 1 diabetes. Beta cell functioning also appears to be preserved in some patients years after apparent loss of pancreatic function. "Traditionally, it was thought that beta cell function completely ceased in patients with advanced type 1 diabetes. However, data from this study and others suggest that the pancreas continues to function at some level even decades after the...

(Ivanhoe Newswire) – New research has found that insulin production may persist for decades after the onset of type 1 diabetes. Beta cell functioning also appears to be preserved in some patients years after apparent loss of pancreatic function. "Traditionally, it was thought that beta cell function completely ceased in patients with advanced type 1 diabetes. However, data from this study and others suggest that the pancreas continues to function at some level even decades after the...

C-peptide production and beta cell functioning detected decades after disease onset Massachusetts General Hospital (MGH) research has found that insulin production may persist for decades after the onset of type 1 diabetes. Beta cell functioning also appears to be preserved in some patients years after apparent loss of pancreatic function. "Traditionally, it was thought that beta cell function completely ceased in patients with advanced type 1 diabetes. However, data from this study and...